PATENT CLAIM ANALYSIS

Application Number: 16040994
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["435", "007920"]

Abstract:
Disclosed herein are antibodies capable of specifically binding to tenofovir (TFV), a key small molecule drug for both the treatment and prevention of HIV, and a competitive lateral flow assay that uses these antibodies to monitor urine samples for the presence of the drug. The assay can be deployed as a point-of-care device for adherence monitoring.

Claim (Index 15):
The device of  claim 11 , wherein the device is positioned in an enclosed housing.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 95.0
- Lexical Diversity: 1.31915
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10236105', '15295547', '15299058', '11932722', '15230238']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5970242803330245
- 35 USC 102 Novelty (BERT): 0.5176039841724666
- Combined Prediction Score: 0.5890822507169687
- Mean Citation Score: 177.53014199999996
- Max Citation Score: 179.40874
- Similarity Product: 82.56722461350383

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test